Open Access
Issue
EPJ Nonlinear Biomed Phys
Volume 1, Number 1, December 2013
Article Number 1
Number of page(s) 13
DOI https://doi.org/10.1140/epjnbp1
Published online 09 May 2013
  1. Information about the Physical Sciences Oncology Centers Network is available through the National Cancer Institute, Center for Strategic Scientific Initiatives. website at: nci.physics@mail.nih.gov
  2. Information about the Cancer Center Support Grant Guidelines and the Cancer Centers program. available at: http://cancercenters.cancer.gov/
  3. Rosenfeld PL: The potential of transdisciplinary research for sustaining and extending linkages between the health and social sciences.Soc Sci Med 1992, 35:1343–57.
  4. Hiatt RA, Haslam ZS, Osuch J: The breast cancer and the environment research centers: Transdisciplinary research on the role of the environment in breast cancer etiology.Breast Cancer and the Environment Research Centers Environmental Health Perspectives 2009,117(12):1814–22.
  5. Gehlert S, McClintock M, Conzen S, Olufunmilayo O: The Importance of Transdisciplinary Collaborations for Understanding and Resolving Health Disparities.Soc Work Public Health 2010, 25:408–422.
  6. Osuch JR, Silk K, Price C, Barlow J, Miller K, Hernick A, Fonfa A: A historical perspective on breast cancer activism in the United States: from education and support to partnership in scientific research.J Womens Health 2012, 21:355–362.
  7. Datta S: Bay Area PS-OC Self Profile.National Cancer Institute Physical Sciences in Oncology Perspectives 2011, 2:4–6.
  8. Dusheck J: Physical scientists take on cancer.Nature 2012, 491:S49-S67.
  9. Information about Project LEAD of National Breast Cancer Coalition. available at the website at: http://www.stopbreastcancer.org
  10. Information about advocacy training at the San Antonio Breast Cancer Symposium. available at: http://www.alamobreastcancer.org and http://www.sabcs.org.
  11. Information about the Survivor and Patient Advocacy Program at the American Association for Cancer Research. available at: http://www.aacr.org
  12. Information about the Advocate Program at the American Association for Clinical Oncology. available at: http://www.asco.org
  13. Information about Komen Advocates in Science is available through Susan G. Komen for the Cure. website at: http://www.komen.org
  14. Information about the trainings offered by the Research Advocacy Network. available at: http://www.researchadvocacy.org
  15. Information about the trainings offered by Genetic Alliance. available at: http://www.geneticalliance.org
  16. Information about the website trainings offered by Cancer Information Services Network. available at: http://www.cisncancer.org
  17. Information about Kay Dickersin, Ph.D. and Musa Mayer’s tutorial, “Understanding Evidence-Based Healthcare: A Foundation for Action”. available on the website: http://us.cochrane.org
  18. Information about the Office of Office of Advocacy Relations is available through the National Cancer Institute. website: http://advocacy.cancer.gov
  19. Information about the U.S. Food and Drug Administration (FDA) Consumer Advisory Committee. available on the FDA website: https://www.fda.gov/AdvisoryCommittees
  20. Information about the Department of Defense (DOD) Breast Cancer Research Program (BCRP). available on the Department of Defense website: http://cdmrp.army.mil/berr
  21. Information about the California Breast Cancer Research Program (CBCRP). available on the website: http://www.cbcrp.org
  22. Baas C: The Role of the Advocate: Helping Unravel the Complexity of Cancer.National Cancer Institute Physical Sciences in Oncology Perspectives 2010, 1:17–18.
  23. Information about the NCI Specialized Programs Of Research Excellence (SPORE). available at the website: http://trp.cancer.gov/
  24. Perlmutter J: Advocate Involvement in I-SPY 2.Breast Diseases: A Year Book Quarterly 2011, 22:21–23. Further information about the I SPY 2 Advocacy Program is available at the website: http://www.gemini-grp.com
  25. Information about the Translational Breast Cancer Research Consortium (TBCRC). available at the website: https://www.web.emmes.com/study/bcrc/
  26. Silk KJ, Neuberger LB, Nazione SA, Ousch J: The Breast Cancer and the Environment Research Centers: a transdisciplinary model. In Contemporary Issues in Health Communication: Theoretical and Practical Case Studies. Edited by Quesry J, Brann M. New York: Springer Publishing; 2010.
  27. Information about the Bay Area Breast SPORE Advocacy Core is available on the UCSF. website: http://cancer.ucsf.edu/research/breast-spore/breast-cancerspore-advocacy-core.
  28. Office of Advocacy Relations at the National Cancer Institute, U.S. Department of Health and Human Services, National Institutes of Health: Advocates in Research Working Group Recommendations. 2011. available at the website: deainfo.nci.nih.gov/advisory/dcig/ARWG-recom.pdf
  29. Samson S: Bay Area Physical-Sciences in Oncology Center (PS-OC) Advocacy Forward: Move It!National Cancer Institute Physical Sciences in Oncology Perspectives 2012, 1:16–17.
  30. Bennett ML, Gadlin H, Levine-Finley S: Collaboration and Team Science: A Field Guide. 2010. Available at the website: http:///teamscience.nih.gov
  31. Drew HC, Pettibone KG, Anderson B, Beard SD, Davis HL, Dilworth CH, O’Fallon L, Collman GW: Partnerships for Environmental Public Health Evaluation Metrics Manual. National Institute of Environmental Health Sciences, U.S. Department of Health and Human Services: NIH Publication No. 12–7825; 2012.
  32. Information about Faster Cures, The Center for Accelerating Medical Solutions, and their blog. available on the website: http://wwwfastercures.org
  33. Information about The Biomarkers Consortium and QuantumLead Healthcare. available on the websites: http://www.biomarkersconsortium.organdhttp://www.quantumleaphealth.org.
  34. Dresser R: When science offers salvation: patient advocacy and research ethics. New York: Oxford University Press; 2001.
  35. Mayer M: A Seat at the Table: A Research Advocate’s Journey.Journal of Participatory Medicine 2009,1(1):e14.
  36. Collyar D: How Have Patient Advocates in the United States Benefited Cancer Research?Nat Rev Cancer 2005, 5:73–78.
  37. Mayer M: Patient Advocacy in Research Merely an Afterthought?Patient 2011,4(2):69–71.
  38. Thompson J, Bissell P, Cooper C, Armitage CJ, Barber R: Credibility and the ‘professionalized’ lay expert: Reflections on the dilemmas and opportunities of public involvement in health research.Health (London) 2012,16(6):602–18.
  39. Epstein S: The construction of lay expertise: AIDS activism and the foregoing of credibility in the reform of clinical trials.Science, Technology, & Human Values 1995, 20:408–437.
  40. Manganiello M, Anderson M: Back to Basics: HIV/AIDS Advocacy As A Model for Catalyzing Change.Strategists and Faster Cures and HCM Strategists 2011, 1–27. available on the website: http://www.hcmstrategists.com/contenBack2Basics_HIV_AIDSAdvocacy.pdf
  41. Information about the National Breast Cancer Coalition’s 2020 deadline challenge can be gleaned from their website. http://www.breastcancerdeadline2020.org/about-nbcc/
  42. ScienceDaily (Sep. 21, 2012): Information about Moon Shots program. available at the website: http://cancermoonshots.org/
  43. Misguided cancer goalNature 2012, 491:637. doi:10.1038/4916379.
  44. Collins FS: Reengineering translational science. The Time is right.Sci Transl Med 2011, 3:1–6.
  45. Sharp PA, Langer R: Promoting Convergence in Biomedical Science.Science 2011, 333:527.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.